Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 7 January 2026

Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk

Nvidia price forecast: Analysts keep $270–$352 targets as China H200 orders turn into the new risk

Nvidia shares climbed 1.3% to $189.59 Wednesday after brokerages raised price targets following CES, with the highest at $352. CEO Jensen Huang said next-gen chips are in full production, aiming for a fivefold AI performance boost. Reports said China asked local firms to halt H200 orders, while U.S. export licenses remain pending. Nvidia’s principal accounting officer sold 80,000 shares last week under a pre-set plan.
7 January 2026
···
Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix shares slipped 0.2% to $90.50 after Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s bid and back Netflix’s offer. Netflix said it has filed required antitrust paperwork and is talking with U.S. and EU regulators. The company reports fourth-quarter results and its outlook on Jan. 20. NFLX trades near the bottom of its 52-week range, below key moving averages.
7 January 2026
····
AMD stock forecast: Shares dip as CES AI-chip rollout meets profit-taking ahead of Feb. 3 earnings

AMD stock forecast: Shares dip as CES AI-chip rollout meets profit-taking ahead of Feb. 3 earnings

AMD shares fell 2.4% to $209.26 in Wednesday afternoon trading, trailing gains in Nvidia and Intel after AMD’s CES launch of new AI chips. The company will report fiscal Q4 and full-year 2025 results on Feb. 3. Investors are watching for guidance on AI chip shipments and margins. Intel unveiled new laptop chips at CES, intensifying competition.
7 January 2026
····
Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

Thermo Fisher stock cools after 52-week high as TD Cowen lifts target ahead of earnings

Thermo Fisher shares slipped 0.2% to $619.19 in afternoon trading Wednesday after hitting a 52-week high Tuesday. TD Cowen raised its price target to $696 and kept a “buy” rating. Investors await CEO Marc Casper’s Jan. 13 conference appearance and Jan. 29 earnings for demand signals. Director Karen S. Lynch received 53.93 phantom stock units, according to a recent Form 4 filing.
7 January 2026
··
Marvell stock slides after $540 million XConn deal — here’s what Wall Street is pricing in

Marvell stock slides after $540 million XConn deal — here’s what Wall Street is pricing in

Marvell shares fell about 4% to $84.57 Wednesday afternoon, reversing gains after announcing a $540 million deal to acquire XConn Technologies. The company expects XConn’s products to add revenue starting in the second half of fiscal 2027. Investors are focused on the delayed revenue impact and execution risks. The drop outpaced broader chip sector declines.
7 January 2026
··
Natural gas price stock UNG jumps as Henry Hub futures rebound; storage report looms

Natural gas price stock UNG jumps as Henry Hub futures rebound; storage report looms

Shares of the United States Natural Gas Fund LP (UNG) rose 4.2% Wednesday as U.S. natural gas futures climbed 3.4% to $3.464/mmBtu on forecasts for cooler weather and higher heating demand. Gas-linked producers, including EQT and Cheniere, also gained. Traders await the U.S. storage report due Jan. 8. U.S. production averaged 109.5 Bcf/d so far this month, with LNG exports at 18.7 Bcf/d.
7 January 2026
·········
Nvidia stock edges up as China pauses H200 orders, complicating AI chip sales

Nvidia stock edges up as China pauses H200 orders, complicating AI chip sales

Nvidia shares rose 1.2% to $189.52 Wednesday after reports that China told some tech firms to pause orders for Nvidia’s H200 chips while it reviews purchase terms. Beijing is expected to steer buyers toward domestic AI chips. The U.S. approved H200 exports last year, requiring Nvidia to share 25% of revenue with the government. Nvidia will report fourth-quarter results on Feb. 25.
7 January 2026
··
Bitcoin price slips as Strategy stock rises on MSCI index reprieve

Bitcoin price slips as Strategy stock rises on MSCI index reprieve

Strategy shares climbed 2% after MSCI paused a plan that could have removed crypto-treasury firms from indexes, while bitcoin slipped 0.7% to $91,253. Coinbase fell 2.5% and the iShares Bitcoin Trust ETF dropped 1.5%. U.S. spot bitcoin ETFs saw $243.2 million in net outflows Tuesday. Traders are watching ETF flows and Friday’s U.S. payrolls report.
7 January 2026
·····
Microchip stock slides after surprise sales forecast — traders look to Feb. 5 for proof

Microchip stock slides after surprise sales forecast — traders look to Feb. 5 for proof

Microchip Technology shares dropped 3% to $72.57 Wednesday, reversing part of Tuesday’s 12% surge after the company raised quarterly sales guidance to about $1.185 billion. Other analog chip stocks, including Texas Instruments and NXP Semiconductors, also declined. Microchip warned that order delays and factory utilization could impact costs if demand softens. Full results are due Feb. 5.
7 January 2026
···
Dow Jones today: Banks drag the index near 50,000 as Friday’s jobs report looms

Dow Jones today: Banks drag the index near 50,000 as Friday’s jobs report looms

The Dow Jones Industrial Average fell 0.17% to 49,376.26 by midday Wednesday, pressured by declines in bank stocks including JPMorgan and Caterpillar. The S&P 500 rose 0.19%, and the Nasdaq gained 0.59%. Labor Department data showed U.S. job openings dropped by 303,000 in November, while ADP reported private payrolls rose by 41,000 in December. Investors await Friday’s government jobs report.
7 January 2026
··
1 … 441 442 443 444 445 … 1,170

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop